Kang S, Onishi S, Ling Z, Inoue H, Zhang Y, Chang H, et al. Gp130-HIF1α axis-induced vascular damage is prevented by the short-term inhibition of IL-6 receptor signaling. Proc Natl Acad Sci USA. 2024;121:e2315898120.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schmaier AA, Anderson PF, Chen SM, El-Darzi E, Aivasovsky I, Kaushik MP, et al. TMEM16E regulates endothelial cell procoagulant activity and thrombosis. J Clin Invest. 2023;133:e163808.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiang P, Chen Q, Chen L, Lei J, Yuan Z, Hu H, et al. Metabolite Neu5Ac triggers SLC3A2 degradation promoting vascular endothelial ferroptosis and aggravates atherosclerosis progression in ApoE-/- mice. Theranostics. 2023;13:4993–5016.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burnstock G. Purine and pyrimidine receptors. Cell Mol Life Sci. 2007;64:1471–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lyle AN, Taylor WR. The pathophysiological basis of vascular disease. Lab Invest. 2019;99:284–9.

Article  PubMed  Google Scholar 

Dubey RK, Fingerle J, Gillespie DG, Mi Z, Rosselli M, Imthurn B, et al. Adenosine attenuates human coronary artery smooth muscle cell proliferation by inhibiting multiple signaling pathways that converge on cyclin D. Hypertension. 2015;66:1207–19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leiva A, Guzmán-Gutiérrez E, Contreras-Duarte S, Fuenzalida B, Cantin C, Carvajal L, et al. Adenosine receptors: modulators of lipid availability that are controlled by lipid levels. Mol Asp Med. 2017;55:26–44.

Article  CAS  Google Scholar 

van Schaick EA, Zuideveld KP, Tukker HE, Langemeijer MW, Ijzerman AP, Danhof M. Metabolic and cardiovascular effects of the adenosine A1 receptor agonist N6-(p-sulfophenyl)adenosine in diabetic Zucker rats: influence of the disease on the selectivity of action. J Pharmacol Exp Ther. 1998;287:21–30.

Article  PubMed  Google Scholar 

Fraser H, Gao Z, Ozeck MJ, Belardinelli L. N-[3-(R)-tetrahydrofuranyl]-6-aminopurine riboside, an A1 adenosine receptor agonist, antagonizes catecholamine-induced lipolysis without cardiovascular effects in awake rats. J Pharmacol Exp Ther. 2003;305:225–31.

Article  CAS  PubMed  Google Scholar 

Liu Z, Yan S, Wang J, Xu Y, Wang Y, Zhang S, et al. Endothelial adenosine A2a receptor-mediated glycolysis is essential for pathological retinal angiogenesis. Nat Commun. 2017;8:584.

Article  PubMed  PubMed Central  Google Scholar 

Gao ZG, Haddad M, Jacobson KA. A2B adenosine receptor signaling and regulation. Purinergic Signal. 2025;21:201–20.

Article  CAS  PubMed  Google Scholar 

Eckle T, Krahn T, Grenz A, Köhler D, Mittelbronn M, Ledent C, et al. Cardioprotection by ecto-5’-nucleotidase (CD73) and A2B adenosine receptors. Circulation. 2007;115:1581–90.

Article  CAS  PubMed  Google Scholar 

Gessi S, Merighi S, Varani K, Leung E, Mac Lennan S, Borea PA. The A3 adenosine receptor: an enigmatic player in cell biology. Pharmaccol Ther. 2008;117:123–40.

Article  CAS  Google Scholar 

Borea PA, Gessi S, Merighi S, Vincenzi F, Varani K. Pharmacology of adenosine receptors: the state of the art. Physiol Rev. 2018;98:1591–625.

Article  CAS  PubMed  Google Scholar 

Eltzschig HK, Sitkovsky MV, Robson SC. Purinergic signaling during inflammation. N Engl J Med. 2012;367:2322–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mo FM, Ballard HJ. The effect of systemic hypoxia on interstitial and blood adenosine, AMP, ADP and ATP in dog skeletal muscle. J Physiol. 2001;536:593–603.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haskó G, Linden J, Cronstein B, Pacher P. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov. 2008;7:759–70.

Article  PubMed  PubMed Central  Google Scholar 

Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol. 2001;41:775–87.

Article  CAS  PubMed  Google Scholar 

Zhou Z, Merkus D, Cheng C, Duckers HJ, Jan Danser AH, Duncker DJ. Uridine adenosine tetraphosphate is a novel vasodilator in the coronary microcirculation which acts through purinergic P1 but not P2 receptors. Pharmacol Res. 2013;67:10–7.

Article  CAS  PubMed  Google Scholar 

Pastor-Anglada M, Pérez-Torras S. Emerging roles of nucleoside transporters. Front Pharmacol. 2018;9:606.

Article  PubMed  PubMed Central  Google Scholar 

Young JD, Yao SY, Baldwin JM, Cass CE, Baldwin SA. The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29. Mol Asp Med. 2013;34:529–47.

Article  CAS  Google Scholar 

Nylander S, Femia EA, Scavone M, Berntsson P, Asztély AK, Nelander K, et al. Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12 antagonism. J Thromb Haemost. 2013;11:1867–76.

Article  CAS  PubMed  Google Scholar 

Casanello P, Torres A, Sanhueza F, González M, Farías M, Gallardo V, et al. Equilibrative nucleoside transporter 1 expression is downregulated by hypoxia in human umbilical vein endothelium. Circ Res 2005;97:16–24.

Article  CAS  PubMed  Google Scholar 

Zhulai G, Oleinik E, Shibaev M, Ignatev K. Adenosine-metabolizing enzymes, adenosine kinase and adenosine deaminase, in cancer. Biomolecules. 2022;12:418.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yegutkin GG. Adenosine metabolism in the vascular system. Biochem Pharmacol. 2021;187:114373.

Article  CAS  PubMed  Google Scholar 

Ciruela F, Albergaria C, Soriano A, Cuffí L, Carbonell L, Sánchez S, et al. Adenosine receptors interacting proteins (ARIPs): Behind the biology of adenosine signaling. Biochim Biophys Acta. 2010;1798:9–20.

Article  CAS  PubMed  Google Scholar 

Wang X, Chen D. Purinergic regulation of neutrophil function. Front Immunol. 2018;9:399.

Article  PubMed  PubMed Central  Google Scholar 

Bahreyni A, Samani SS, Rahmani F, Behnam-Rassouli R, Khazaei M, Ryzhikov M, et al. Role of adenosine signaling in the pathogenesis of breast cancer. J Cell Physiol. 2018;233:1836–43.

Article  CAS  PubMed  Google Scholar 

Fredholm BB, Jacobson APIJ, Linden KA, Müller J. Fredholm BB, IJzerman AP, Jacobson KA, Linden J, Müller CE. International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors-an update. Pharmacol Rev. 2011;63:1–34.

Wendlandt M, Kürten AJ, Beiersdorfer A, Schubert C, Samad-Yazdtchi K, Sauer J, et al. A2A adenosine receptor-driven cAMP signaling in olfactory bulb astrocytes is unaffected in experimental autoimmune encephalomyelitis. Front Immunol. 2023;14:1273837.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koupenova M, Johnston-Cox H, Vezeridis A, Gavras H, Yang D, Zannis V, et al. A2b adenosine receptor regulates hyperlipidemia and atherosclerosis. Circulation. 2012;125:354–63.

Article  CAS  PubMed